Market research
ADR.AU Adherium Limited
AU AUD Healthcare
Latest close
As of 26 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.8906
- Dividend yield
- Not available
- Beta
- 1.12
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU000000ADR1
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.8906
- Dividend yield
- Not available
- Beta
- 1.12
About
About Adherium Limited
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patient Monitoring (RPM) Solution. It operates in New Zealand, Australia, South East Asian Countries, and North America. Adherium Limited was founded in 2001 and is based in Melbourne, Australia.
Research context
Adherium Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ADR.AU discussion.
5 years, 6 months ago
Adherium Limited is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.
From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.
Adherium Limited's total revenue sank by 82.2% to $253K since the same quarter in the previous year.
Its net income has dropped by 91.5% to $-9M since the same quarter in the previous year.
Finally, its free cash flow fell by 75.7% to $-3M since the same quarter in the previous year.
Based on the above factors, Adherium Limited gets an overall score of 1/5.